Kenneth Inchausti

Corporate Officer/Principal bei Novo Nordisk, Inc.

Health Technology

Consumer Services

Aktive Positionen von Kenneth Inchausti

Unternehmen	Position	Beginn	Ende
Novo Nordisk, Inc. Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ.	Corporate Officer/Principal	25.09.2014	-
	Public Communications Contact	-	25.09.2014

Unternehmen	Position	Beginn	Ende
OCUGEN, INC.	Investor Relations Kontakt	21.06.2021	01.06.2022
OCUGEN, INC.	Public Communications Contact	21.06.2021	01.06.2022

Old Dominion University

Undergraduate Degree

International

Vereinigte Staaten

Operativ

Public Communications Contact	2
Corporate Officer/Principal	1
Undergraduate Degree	1

Sektoral

Health Technology	3
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
OCUGEN, INC.	Health Technology

Private Unternehmen	1
Novo Nordisk, Inc. Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ.	Health Technology

Private Unternehmen

Health Technology